REG - Carclo plc - Notice of Interim Results & Investor Presentation

CarcloAnnouncement

15/11/2022 07:16

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221115:nRSO3695Ga&default-theme=true

RNS Number : 3695G  Carclo plc  15 November 2022

15 November 2022

 

Carclo plc

 

Notice of Interim Results and Investor Presentation

 

Carclo plc will announce its Interim Results for the period ended 30 September
2022 at 7.00 am on Wednesday 30 November 2022.

 

Frank Doorenbosch, Chief Executive Officer, and David Bedford, Chief Financial
Officer, will provide a live presentation relating to the Interim Results for
the period ended 30 September 2022 via the Investor Meet Company platform on
30 November 2022 at 10.00 am (GMT).

 

The presentation is open to all existing and potential shareholders.
Questions can be submitted pre-event via your Investor Meet Company dashboard
up until 9.00 am (GMT) the day before the meeting or at any time during the
live presentation.

 

Investors can sign up to Investor Meet Company for free and add to meet Carclo
plc via the following link:

 

https://www.investormeetcompany.com/carclo-plc/register-investor
(https://www.investormeetcompany.com/carclo-plc/register-investor)

Investors who already follow Carclo plc on the Investor Meet Company platform
will be invited automatically.

 

 

About Carclo plc

Carclo plc is a public company whose shares are quoted on the Main Market of
the London Stock Exchange. The Group is a global provider of value-adding
engineered solutions for the medical, optical and aerospace industries.

 

 

LEI: 21380078MEM399JPI956

 

Enquiries:

 Carclo plc                                   01924 268040
 Frank Doorenbosch - Chief Executive Officer
 David Bedford - Chief Financial Officer

 FTI Consulting                               020 3727 1340
 Nick Hasell / Susanne Yule

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOREAPFLFLKAFFA